Datacorp has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI) for $1.28 million to advance developments in patient-reported outcomes (PRO) measures for adults with asthma. This project will finalize development of a patient-based assessment that combines asthma health-related quality of life (HRQOL) impact, asthma control, and generic HRQOL outcomes measures. Datacorp will collaborate with Kaiser Permanente’s Southern California Permanente Medical Group and Advise & Consent on this project.
NIH’s SBIR program is designed for domestic small business concerns engaging in research and development efforts that have strong potential for commercialization and public benefit. SBIR grant proposals undergo rigorous peer review by independent scientists and the funding agency. Grant awards are made on the basis of technological innovation, scientific merit, commercialization, and corporate potential.
Dr. Diane Turner-Bowker, Datacorp’s Director of Research & Development and Principal Investigator on the project states, “In patient-centered care, the patient’s perspective on asthma is valued and information regarding the patient’s experience is considered in clinical care. Patient-reported outcome (PRO) measures, like those under development in our Phase II SBIR project, help capture critical data relating to asthma control and asthma burden from the patient’s perspective. This information can be used to screen, assess, and monitor patients over time, and may improve patient-provider communication and treatment decision-making.”